Boutigny sur Essonne, France

Christel Riviere

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genethon. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christel Riviere. Retrieved from https://idiyas.com/inventor/christel-riviere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christel Riviere: Innovator in Gene Therapy

Introduction

Christel Riviere is a talented inventor based in Boutigny sur Essonne, France. With a focus on advanced biotechnological applications, she has made significant contributions to the field of gene therapy through her innovative research.

Latest Patents

Christel Riviere holds one patent titled "Baculovirus expression systems." This invention pertains to an optimized baculovirus construct that is particularly useful for the production of virus-like particles or viral vectors. These vectors are essential for gene therapy, helping to deliver genetic material into cells effectively.

Career Highlights

She currently works at Genethon, a renowned organization specializing in gene therapy development. At Genethon, Christel has been instrumental in advancing technologies that aim to treat genetic disorders and improve patient outcomes.

Collaborations

Throughout her career, Christel has collaborated with notable professionals in the industry, including Lionel Galibert and Otto-Wilhelm Merten. These collaborations highlight her commitment to working alongside other experts to enhance the scientific community’s understanding of gene therapy.

Conclusion

Christel Riviere is a prominent figure in the realm of biotechnology, and her innovative patent plays a crucial role in the progression of gene therapy. Her work continues to inspire future innovations in the field, proving the importance of dedicated researchers in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…